Wednesday, November 17, 2021
Print Current Session:
|
|
Wednesday
SESSION 25:
LOWER EXTREMITY TOPICS RELATED TO THE DRUG COATED DEVICES CAUSING INCREASED MORTALITY CONTROVERSY: DO PACLITAXEL COATED DEVICES CAUSE INCREASED MORTALITY (5 AND 4 ¾-MINUTE SHORT SUMMARY [SS] TALKS)
|
|
SESSION 25 SCHEDULE | |
9:00 AM - 9:05 AM | Older And More Recent Meta-Analyses Reveal An Increased Mortality Signal In Patients Receiving Paclitaxel Coated Devices Compared To Uncoated Devices: The More Recent Study Of DCBs In BTK Arteries Showed Increased Mortality And Amputation Rates After Only 1 Year |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR Location: Grand Ballroom East, 3rd Floor |
|
9:06 AM - 9:11 AM | How Do Paclitaxel And Limus Drugs Work And Differ In Safety And Effectiveness In Inhibiting Intimal Hyperplasia Induced By Treatment |
Presenter(s):Juan F. Granada, MD Location: Grand Ballroom East, 3rd Floor |
|
9:12 AM - 9:17 AM | Summary Of The Present Status Of The Paclitaxel Mortality Controversy With DCBs And DESs Treatments In The SFA And BTK Arteries |
Presenter(s):Andrew Holden, MBChB Location: Grand Ballroom East, 3rd Floor |
|
9:18 AM - 9:23 AM | Alternatives To Paclitaxel Coated Devices For Limiting Intimal Hyperplasia After Treatment: Sirolimus Coating, Bioresorbables And Advential Drug Delivery With The Bullfrog Device: Is The Paclitaxel Mortality Signal Real |
Presenter(s):William A. Gray, MD Location: Grand Ballroom East, 3rd Floor |
|
9:24 AM - 9:29 AM | Real World Big Data Patient-Level Evidence Confirms No Harm From Paclitaxel Coated Devices For Treating Fempop Disease: Update On Medicare Data From Over 150,000 Patients |
Presenter(s):Eric A. Secemsky, MD, MSc / Robert Yeh, MD Location: Grand Ballroom East, 3rd Floor |
|
9:30 AM - 9:35 AM | Large Population Based German Multicenter Study Of Paclitaxel Coated BTK DCBs And DESs Indicates Decreased Mortality And Amputation Rates Compared To Uncoated Devices |
Presenter(s):Christian A. Behrendt, MD Location: Grand Ballroom East, 3rd Floor |
|
RELEVANT COMMENTS AS SHORT SUMMARY [SS] TOPICS (4 ¾-MINUTE TALKS) | |
9:36 AM - 9:41 AM | [SS] The Paclitaxel Increased Mortality Effect Reported By Dr. Katsanos et al. Seems Not To Be Confirmed By Added Data |
Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor |
|
9:41 AM - 9:46 AM | [SS] Is The Paclitaxel Increased Mortality Signal Incorrect: The Updated Collected VIVA Data Do Not Confirm It |
Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom East, 3rd Floor |
|
9:46 AM - 9:51 AM | [SS] The Current Japanese View On The Paclitaxel Mortality Signal |
Presenter(s):Osamu Iida, MD Location: Grand Ballroom East, 3rd Floor |
|
9:51 AM - 9:56 AM | [SS] VQI Data Do Not Support The Paclitaxel Increased Mortality Signal |
Presenter(s):Daniel Bertges, MD / Jack L. Cronenwett, MD Location: Grand Ballroom East, 3rd Floor |
|
9:56 AM - 10:01 AM | [SS] Progress And Problems With A Sustained Release Limus DCB: 2-Year Results With The Magic Touch DCB: From The SIRONA Study |
Presenter(s):Dierk Scheinert, MD / Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
10:01 AM - 10:08 AM | Panel Discussion |
10:08 AM - 10:18 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 25 | |
previous | next |